Introduction • Major developments in bladder cancer continue! • ESMO – 1. mUC upfront combinations – Keynote 361, Danube – 2. mUC Biomarker Evaluation – Javelin Maintenance Study – 3. mUC Third Line – Trophy U- 01 9